📰 Galaxy Development News
Galaxy Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Galaxy Development. Real-time updates on events, politics, business and more.
October 29, 2023
A look at Central Mass. business news over the past week.
September 28, 2023
Galaxy Life Sciences is seeking Planning Board approval to expand its project at The Reactory from 95,000 to 246,000 square feet.
April 19, 2023
Developers and brokers are using multiple strategies to bring life sciences companies out past Route 128 in Massachusetts. They cite less expensive real estate, a strong talent pool, shorter commutes, and increasing amenities like culture, sports, and food as reasons to set up shop in Central Massachusetts.
February 22, 2023
Galaxy Life Sciences of Webster bought two parcels for $3.3 million and a third for $700,000, adding tenant space to The Reactory, a 46-acre campus.
February 17, 2023
Webster developer Galaxy Life Sciences purchased the final three lots at The Reactory biomanufacturing campus on Belmont Street in Worcester for $4 million on Thursday.
January 23, 2023
With new building codes on the horizon, battles will be fought in the name of progress, as developers and various interest groups are hesitant to make sweeping changes to make constructing the things their communities need more expensive and difficult to bring to fruition via constrictive rules.
December 29, 2022
Galaxy Links, LLC, registered to Galaxy Development principal Michael O’Brien, has purchased Sutton’s Pleasant Valley Country Club.
October 10, 2022
They are decorative art and colorful billboards beautifying the area landscape with a bit of history, a touch of whimsy and a lot of hometown pride.
January 25, 2021
When Matt Zicaro joined forces with Michael O’Brien of Galaxy Development, they launched a new development firm – Galaxy Life Sciences – committed to building out the bioscience industry in Central Massachusetts, particularly at The Reactory biomanufacturing campus in Worcester. Aside from the section of the Reactory to be occupied by the $60-million facility of Chinese biomanufacturer WuXi Biologics, Galaxy has optioned the rest for its future developments, the first of which will be a $...